Selected Publication:
Lipp, RW; Schnedl, WJ; Stauber, R; Ranner, G; Leb, G; Krejs, GJ.
Scintigraphic long-term follow-up of a patient with metastatic glucagonoma.
Am J Gastroenterol. 2000; 95(7):1818-1820
Doi: 10.1111/j.1572-0241.2000.02164.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Leading authors Med Uni Graz
-
Lipp Rainer
- Co-authors Med Uni Graz
-
Krejs Günter Josef
-
Leb Georg
-
Schnedl Wolfgang
-
Stauber Rudolf
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Two years after resection of a pancreatic glucagonoma, scintigraphy with 111indium-labeled octreotide revealed hepatic metastases in a 48-yr-old man. Hepatic metastases were also visualized by CT, whereas an additional lesion in the chest was seen only by scintigraphy. A total of 11 follow-up examinations over 46 months proved somatostatin receptor scintigraphy to monitor reliably somatostatin receptor expression, growth and dissemination of glucagonoma metastases, and to indicate therapeutic readjustment if necessary. The survival time of the patient is now >75 months, in comparison with a mean survival time of 59 months reported for metastatic glucagonoma.
- Find related publications in this database (using NLM MeSH Indexing)
-
Follow-Up Studies -
-
Glucagonoma - diagnostic imaging
-
Glucagonoma - secondary
-
Humans -
-
Liver Neoplasms - diagnostic imaging
-
Liver Neoplasms - secondary
-
Male -
-
Middle Aged -
-
Pancreatic Neoplasms - pathology
-
Radionuclide Imaging -
-
Time Factors -